Meta-Analysis of Antinuclear Antibodies in the Diagnosis of Antimitochondrial Antibody-Negative Primary Biliary Cholangitis
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Objective. The diagnostic value of antinuclear antibodies (ANAs) including anti-gp210 and anti-sp100 for primary biliary cholangitis/cirrhosis (PBC) has been widely reported. However, their diagnostic performances for antimitochondrial antibody- (AMA-) negative PBC were less well elucidated. Therefore, the aim of the current meta-analysis was to evaluate the diagnostic accuracy of ANAs in patients with AMA-negative PBC.Materials and Methods. Literature on the diagnostic value of biomarkers for AMA-negative PBC was systematically searched in PubMed, MEDLINE, EMBASE, and the Cochrane Library. The qualities of the retrieved studies were assessed by the Quality Assessment of Diagnostic Accuracy Studies-version 2 (QUADAS-2) scale. Pooled sensitivity and specificity of the biomarkers were calculated with random-effects models. The areas under the summary receiver operating characteristic (AUSROC) curves were used to evaluate the overall diagnostic performance of ANAs.Results. A total of 11 studies (400 AMA-negative PBC patients and 6217 controls) were finally included in the meta-analysis. ANAs had an overall sensitivity of 27% (95% CI: 20%, 35%) and specificity of 98% (95% CI: 97%, 99%). The pooled sensitivities for anti-gp210 and anti-sp100 were 23% (95% CI: 13%, 37%) and 25% (95% CI: 13%, 43%), respectively, and their specificities were 99% (95% CI: 97%, 100%) and 97% (95% CI: 93%, 98%), respectively.Conclusions. ANAs exhibited high specificity but low sensitivity and therefore could be used as reliable biomarkers to reduce the necessity of liver histology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Both anti-gp210 and anti-sp100 show low sensitivities (23% for anti-gp210 and 25% for anti-sp100), but high specificity (over 95%) for anti-mitochondrial antibody-negative primary biliary cholangitis.53”
From Primary biliary cholangitis. (2024) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Deeks, J. J., Macaskill, P., & Irwig, L. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.01.016 · Cited by 2,910 · cited 1×
“Deeks’ test was used to detect funnel plot asymmetry in reviews of diagnostic studies to investigate publication bias [22].”
MethodHirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480 · cited 2×
“According to major international guidelines, the diagnosis of PBC can be confidently made in patients with clinical, biochemical, and radiological evidence of intrahepatic cholestasis if they are positive for AMA [3, 4].”
BackgroundLindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913 · cited 4×
“This is especially relevant for patients with high suspicion of PBC but negative for AMA and probably could reduce the necessity of liver histology in this setting [3].”
BackgroundInfluentialCarey, E. J., Ali, A. H., & Lindor, K. D. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00154-3 · Cited by 735
Management of primary biliary cirrhosis
Heathcote, J. E. (2000) · Hepatology · doi:10.1053/he.2000.5984 · Cited by 417
Hirschfield, G. M., Dyson, J. K., Alexander, G. J. M., Chapman, M. H., Collier, J., Hübscher, S., Patanwala, I., Pereira, S. P., Thain, C., Thorburn, D., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315259 · Cited by 362
Invernizzi, P., Crosignani, A., Battezzati, P. M., Covini, G., De Valle, G., Larghi, A., Zuin, M., & Podda, M. (1997) · Hepatology · doi:10.1002/hep.510250507 · Cited by 293
Cochrane diagnostic test accuracy reviews
Leeflang, M. M., Deeks, J. J., Takwoingi, Y., & Macaskill, P. (2013) · Systematic Reviews · doi:10.1186/2046-4053-2-82 · Cited by 292
Szostecki, C., Guldner, H. H., Netter, H. J., & Will, H. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4338 · Cited by 269
Cited by
Tanaka, A., Ma, X., Takahashi, A., & Vierling, J. M. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01303-5 · Cited by 177
You, H., Ma, X., Efe, C., Wang, G., Jeong, S.-H., Abe, K., Duan, W., Chen, S., Kong, Y., Zhang, D., et al. (2022) · Hepatology International · doi:10.1007/s12072-021-10276-6 · Cited by 133
Self-citationGuidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021)
You, H., Duan, W., Li, S., Lv, T., Chen, S., Lu, L., Ma, X., Han, Y., Nan, Y., Xu, X., et al. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00347 · Cited by 46
Self-citationVillalta, D., Seaman, A., Tiongson, M., Warren, C., Bentow, C., Bizzaro, N., Alessio, M. G., Porcelli, B., Norman, G. L., & Mähler, M. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0122 · Cited by 28
Concentration of Serum Matrix Metalloproteinase-3 in Patients With Primary Biliary Cholangitis
Bauer, A., & Habior, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.885229 · Cited by 25
Changes of Serum IgG Glycosylation Patterns in Primary Biliary Cholangitis Patients
Zeng, X., Li, S., Tang, S., Li, X., Zhang, G., Li, M., Zeng, X., & Hu, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669137 · Cited by 24
Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis Overlap Syndrome: A Review
Mago, S., & Wu, G. Y. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00036 · Cited by 22
Bauer, A., Habior, A., Wieszczy, P., & Gaweł, D. (2021) · Diagnostics · doi:10.3390/diagnostics11040587 · Cited by 18
Bauer, A., Habior, A., & Gaweł, D. (2022) · Biomedicines · doi:10.3390/biomedicines10040801 · Cited by 17
Qian, J., Yao, T.-T., Wang, Y., & Wang, G. (2020) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2020.03.026 · Cited by 15
Anti-gp210 and anti-Sp100 antibodies in primary biliary cholangitis
Lamine, Z. B., Jazia, I. B., Ahmed, M. B., Slama, A. B., Baccouche, A., Slama, F., Jemaa, A., Ghédira, I., & Mankaï, A. (2021) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2021.05.006 · Cited by 15
Jaskowski, T. D., Nandakumar, V., Novis, C. L., Palmer, M., & Tebo, A. E. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117219 · Cited by 12
Bin, L., Liu, Z., & Xu, L. (2020) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2020.7483/2020 · Cited by 12
Self-citationGuatibonza-García, V., Gaete, P. V., Pérez-Londoño, A., Puerto-Baracaldo, D. K., Gutiérrez-Romero, S. A., Mendivil, C. O., & Tapias, M. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i29.4890 · Cited by 11
Autorinnen/Autoren, & Collaborators (2025) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2558-5204 · Cited by 10
The latest research trends in primary biliary cholangitis: a bibliometric analysis
Zhao, Y., Yin, Z., Du, H., Huang, K., Zhang, F., & Chen, H. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00825-0 · Cited by 9
Circulating Monocyte Chemoattractant Protein-1 (MCP-1) in Patients with Primary Biliary Cholangitis
Bauer, A., & Rawa, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021333 · Cited by 8
[Guidelines on the diagnosis and management of primary biliary cholangitis (2021)].
(2021) · PubMed Central · doi:10.3760/cma.j.cn112138-20211112-00794 · Cited by 8
Autoantibodies in the diagnostics, prognostics and follow-up of primary biliary cholangitis
Antal‐Szalmás, P., Bencze, D., Demeter, S., Pénzes, K., Szabó, L., Tóth, B., Földesi, R., Papp, M., & Nagy, G. (2026) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2026.100366 · Cited by 5
Huang, C., Liu, Y. M., Liu, H., Xu, B., Yan, H. P., Zhang, H. P., Liao, H., Zhang, X. D., Zhao, J., Li, W. J., et al. (2022) · PubMed Central · doi:10.3760/cma.j.cn501113-20210501-00216 · Cited by 5
АUTOANTIBODIES IN AUTOIMMUNE LIVER DISEASES (REVIEW OF LITERATURE)
Александрова, Е. Н., Dorofeev, A. S., Novikov, A. A., & Sandler, Y. G. (2023) · Russian Clinical Laboratory Diagnostics · doi:10.51620/0869-2084-2023-68-8-464-474 · Cited by 4
Dalekos, G., Gatselis, N., Ανδρουτσάκος, Θ., Samonakis, D. N., Triantos, C. K., TINIAKOS, D. G., & Rigopoulou, E. I. (2026) · Annals of Gastroenterology · doi:10.20524/aog.2026.1048 · Cited by 4
Acharya, S., Shrestha, S., Poddar, E., Neupane, A., Khadayat, R., Magar, S. R., Lamsal, M., & Pathak, R. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001143 · Cited by 3
Ma, H., Liu, Y., Zhu, Y., Xu, G. Q., Xiang, X., Xue, S., Zhang, Z., Cheng, C., Lu, F., Wang, B., et al. (2025) · Immunology Letters · doi:10.1016/j.imlet.2025.107100 · Cited by 3
Sebode, M., Bantel, H., Baumann, U., Bufler, P., Demir, M., Dold, L., Keitel, V., Klein, R., Kremer, A. E., Jansen, P. L., et al. (2026) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2769-2475 · Cited by 2
Scheme 8-Isoprostane and Interleukin-8 Levels in Patients with Primary Biliary Cholangitis
Bauer, A., & Habior, A. (2023) · International Electronic Conference on Biomedicines (IECBM) · doi:10.3390/ecb2023-14139 · Cited by 2
Saipiyeva, D., Askarov, M. B., Jafari, N., Zhankina, R. A., Heath, P. R., Kozina, L., Boltanova, A., Omarbekov, A., Ilyassov, N., Tuganbekov, T., et al. (2024) · PubMed Central · doi:10.30476/ijms.2023.99613.3172 · Cited by 2
Ran, Y., Wang, X. Y., Yang, Z., Li, J. W., Zhang, X., Shen, M., Wang, X. Y., Jia, H., Han, Z., Yang, H., et al. (2025) · PubMed Central · doi:10.3760/cma.j.cn501113-20250504-00170 · Cited by 2
Yang, M., Hu, C., Huang, J., Fu, Y., Zhang, Q., Cheng, Y., Lu, J., Li, G., & Zhang, J. (2024) · Journal of Laboratory Medicine · doi:10.1515/labmed-2023-0127 · Cited by 1
Self-citationTrivella, J. P., & Levy, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-26710-9.00018-3 · Cited by 1
Evaluation of autoimmune biomarkers in vitiligo patients' serum
(2023) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.47750/jptcp.2023.1115 · Cited by 1
AASLD AGA clinical Practice Guideline on management of primary biliary cholangitis
Levy, C., Mayo, M. J., Carey, E. J., Chen, V. L., Assis, D. N., Goel, A., Sedki, M., Sultan, S., Taddei, T. H., Bittermann, T., et al. (2026) · Hepatology · doi:10.1097/hep.0000000000001875 · Cited by 1
Austrian Society of Gastroenterology and Hepatology (ÖGGH) consensus on primary biliary cholangitis
Halilbasic, E., Tatscher, E., Aigner, E., Burghart, L., Graziadei, I. W., Hametner‐Schreil, S., Hofer, B., Hofer, H., Maieron, A., Mandorfer, M., et al. (2026) · Wiener klinische Wochenschrift · doi:10.1007/s00508-026-02798-6
Bauer, A., Rawa, T., & Bauer, T. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198461
Clinical features in primary biliary cholangitis:A retrospective analysis of 67 casesPreprint
Zhou, J., Li, S., Chen, M., Zhou, F., Liu, J., Chen, L., & Ren, J. (2024) · Research Square · doi:10.21203/rs.3.rs-3975134/v1
AGA/AASLD Clinical Practice Guideline on Management of Primary Biliary Cholangitis
Levy, C., Mayo, M. J., Carey, E. J., Chen, V. L., Assis, D. N., Goel, A., Sedki, M., Sultan, S., Taddei, T., Bittermann, T., et al. (2026) · Gastroenterology · doi:10.1053/j.gastro.2026.08.025
Biomarker discovery for UDCA response evaluation in Primary Biliary Cholangitis
Kati, D. (2024) · UCL Discovery (University College London)
Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases
Wang, J. (2023) · MDPI eBooks · doi:10.3390/books978-3-0365-7738-8
Rsaliyeva, Z., Oshibayeva, A., Gaipov, A., Nuskabayeva, G. O., Iskandirova, E., Dossybayeva, G., Рсалиева, Ж. М., Sakhova, B. O., Kistaubayev, M. U., & Annaorazova, Z. I. (2026) · Ġylym men densaulyķ saķtau. · doi:10.34689/sh.2026.28.5.se.020
Roberto, R. (2025) · Gastroenterology and hepatology from bed to bench. · doi:10.22037/ghfbb.v18i3.3135
Metadata
- Authors
- Zhang, Q., Liu, Z., Wu, S., Duan, W., Chen, S., Ou, X., You, H., Kong, Y., & Jia, J.
- Affiliations
- Capital Medical University (CN)
- Fujian Medical University (CN)
- Corresponding author
- Kong, Yuanyuan
- Jia, Jidong
- Venue
- Gastroenterology Research and Practice
- Publisher
- Wiley
- Published
- 2019-06-10
- Volume
- 2019
- Pages
- 1-12
- ISSN
- 1687-6121 (ISSN-L)
- 1687-630X
- PMC
- PMC6590611
- OpenAlex
- W2952950257
- Cited by
- 28
- References
- 42
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 5 · 2023: 5 · 2022: 4 · 2021: 4 · 2020: 4
- FWCI
- 0.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Gastroenterology Research and Practice (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Science and Technology Major Special Project for Infectious Diseases (2018ZX10302204, 2018ZX09201016, XXZ0203, XXX0104)
- National Science and Technology Major Special Project for New Drug Development (2018ZX10302204, 2018ZX09201016, XXZ0203, XXX0104)
- Beijing Municipal Administration of Hospitals (2018ZX10302204, 2018ZX09201016, XXZ0203, XXX0104)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Keywords
- antinuclear antibodies, primary biliary cirrhosis, diagnostic accuracy, sensitivity and specificity, biomarkers, liver histopathology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.